The Impact of Oral ED Medication on Female Partners’ Relationship Satisfaction

McCabe, Marita P.; O’Connor, Elodie; Conaglen, John V.; Conaglen, Helen M.

doi:10.1111/j.1743-6109.2010.02094.x

Cited by 14 publications

(11 citation statements)

References 21 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the absolute number of participating partners makes REPEAT the largest prospective relationship quality study where the male partner has ED. Similar improvements in relationship quality were described in a previous study in couples (n ¼ 96), in which treatment of the man's ED with tadalafil or sildenafil was associated with an improvement in the female partner's perception of their relationship quality [10]. Successful pharmacological treatment of ED may thus benefit and support non-medical approaches to addressing relationship problems, such as relationship counselling and psychosexual therapy.…”

Section: Discussionsupporting

confidence: 77%

See 1 more Smart Citation

The real-life perception of efficacy, attitude, satisfaction and safety of vardenafil therapy (REPEAT): a prospective, non-interventional, observational study

2014

View full text Add to dashboard Cite

This study assessed the improvement in relationship quality, effectiveness and safety associated with vardenafil for the treatment of erectile dysfunction (ED). The study was conducted in 1433 centres across 21 countries and comprised a baseline patient visit and up to four follow-up visits during an observational period of 1 year. Relationship quality, happiness, satisfaction with vardenafil treatment, and safety and tolerability were assessed by physician interviews and patient and partner questionnaires. Overall, 7496 patients were enrolled in the study, of which 7430 were included in the safety analyses and 6470 in the effectiveness analyses. Relationship quality, assessed by a relationship questionnaire (partnerschaftsfragebogen [PFB]), was improved at last observation carried forward, compared with baseline, in both patients and partners and satisfaction with the effectiveness of vardenafil treatment was high. Vardenafil was well tolerated and adverse events were consistent with the known safety profile of phosphodiesterase type 5 inhibitors. These results confirm the well-established effectiveness and safety profiles of vardenafil. This study is the first to demonstrate improvements in relationship quality following vardenafil therapy, in both patients and partners, using the PFB questionnaire.

show abstract

Section: Discussionsupporting

confidence: 77%

“…The FEMALES study demonstrated an improvement in the sexual experience in women whose partners were treated for ED [3]. Similarly, PDE-5 inhibitor therapy can have beneficial effects on the sexual quality of life of the female partner, as well as improving relationship quality [10].…”

Section: Introductionmentioning

confidence: 98%

The real-life perception of efficacy, attitude, satisfaction and safety of vardenafil therapy (REPEAT): a prospective, non-interventional, observational study

2014

View full text Add to dashboard Cite

show abstract

“…However, sexual satisfaction is interrelated with that of a female partner. Treatment of men ED by using oral PDE5 was followed by improvement of female partners quality of life and positive effects on their perception of the quality of their relationship [32,33]. On that point, Porena et al.…”

Section: Discussionmentioning

confidence: 99%

High Patient Satisfaction After Inflatable Penile Prostheses Implantation Correlates with Female Partner Satisfaction

Vakalopoulos

Kampantais

Ioannidis

et al. 2013

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Patient and female partner satisfaction after implantation of an inflatable penile prosthesis (IPP) assessed by objective means, and the correlation between the partners, is important for determining postoperative sexual life. Aim The primary goal was to evaluate patients' erectile function and patients' and their partners' satisfaction after IPP implantation. A secondary aim was to investigate potential determinative factors of satisfaction according to device characteristics, demographics, and cause of erectile dysfunction (ED). Methods Ninety patients, who underwent IPP implantation as an alternative to refractory or undesirable medical treatment for ED, were evaluated. Patients who could not or refused to participate, or were out of a relationship, were excluded. The 69 remaining patients were evaluated for their pre- and postoperative erectile function and posttreatment satisfaction for themselves and their partners. Main Outcome Measures Preoperative and postoperative scores on the International Index of Erectile Function Questionnaire–five items (IIEF-5) were compared. The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) was given to males and their female partners. Patient demographics, etiology of ED, and implant characteristics were correlated also with patients' EDITS scores. Results Mean IIEF-5 scores demonstrated a significant improvement after IPP implantation: from 8.88 ± 3.75 to 20.97 ± 4.37 (P < 0.001). The mean patients' EDITS score was 75.48 ± 20.54, whereas mean female partners' score was 70.00 ± 22.92, highlighting high posttreatment satisfaction for both. Regression analysis suggested a direct linear correlation of satisfaction between the sexual partners as a degree of satisfaction. There were no statistically significant differences according to level of education or implant characteristics. Concerning the etiology of ED, no conclusions could be made. Conclusions Overcoming previous limitations in determining post-IPP implantation satisfaction, our study reiterates high rates of patient and partner satisfaction. Of particular note, patient satisfaction appears independent of prosthesis type and cylinder length.

show abstract

“…Treatment satisfaction was defined as an EDITS Index or EDITS Partner Index score X50, and treatment dissatisfaction as an Index score o50. The severity of ED was based on the total SHIM score, with 22-25 representing no ED, 17-21 representing mild ED, 12-16 representing mild to moderate ED, [8][9][10][11] representing moderate ED and o7 representing severe ED. 22 …”

Section: Questionnairesmentioning

confidence: 99%

“…Medical-treatment-related improvement in erectile function has been associated with enhanced quality of life, increased self-esteem and a reduction in depressive symptoms in patients with ED, 6 as well as improvement in several aspects of sexual function of their untreated female partners. [7][8][9] In spite of these reported improvements, there is a high dropout rate among PDE5 inhibitor responders, which ranges from 57 to 31%. 10,11 Although the reasons for the high dropout rate are diverse, female partners of men with ED are thought to have a key supportive role in the successful long-term treatment of ED.…”

Section: Introductionmentioning

confidence: 99%

Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction

Jiann

2013

Int J Impot Res

View full text Add to dashboard Cite

The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) and its partner version questionnaire were used to assess couples' satisfaction with the use of phosphodiesterase type 5 (PDE5) inhibitors to treat erectile dysfunction (ED) over a 3-month period. Of 161 ED patients, who together with their female partners were invited to answer separate questionnaires at home, 111 patients (68.9%; mean age 61.8 (23-87) years) and female partners (mean age 52.8 (22-77) years) returned completed questionnaires. Patients reported a substantially higher treatment satisfaction score and level of satisfaction with ED treatment than their female partners (Po0.001). Patients with milder severity of ED at baseline and better erectile function after treatment were more likely to be satisfied with the outcome of the treatment. Of the different aspects of satisfaction that patients were asked about, they reported the lowest level of satisfaction about their partners' feeling about continued treatment for ED. Our study shows that more patients than their female partners are more satisfied with medical treatment for ED. To maintain long-term therapy for ED, it is important to include female partners in the assessment and management of the therapy.

show abstract

The Impact of Oral ED Medication on Female Partners’ Relationship Satisfaction

Cited by 14 publications

References 21 publications

The real-life perception of efficacy, attitude, satisfaction and safety of vardenafil therapy (REPEAT): a prospective, non-interventional, observational study

The real-life perception of efficacy, attitude, satisfaction and safety of vardenafil therapy (REPEAT): a prospective, non-interventional, observational study

High Patient Satisfaction After Inflatable Penile Prostheses Implantation Correlates with Female Partner Satisfaction

Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction

Contact Info

Product

Resources

About